Pharmacology, Toxicology and Pharmaceutical Science
Chronic Lymphatic Leukemia
100%
Cytarabine
65%
Fludarabine
63%
Acute Myeloid Leukemia
55%
Leukemia
39%
Clofarabine
35%
Pharmacokinetic
29%
Adenosine Triphosphate
28%
Adenosine
25%
Hematologic Malignancy
22%
Pharmacodynamics
22%
Cytotoxicity
21%
Multiple Myeloma
20%
Diseases
19%
Venetoclax
19%
Malignant Neoplasm
19%
Acute Leukemia
19%
Phosphotransferase Inhibitor
18%
Nelarabine
18%
Nucleoside Analog
18%
Clinical Trial
17%
Ibrutinib
17%
Gemcitabine
15%
Remission
15%
Cytidine Triphosphate
14%
Cladribine
13%
Nucleoside
13%
Antiapoptotic
13%
Combination Therapy
12%
Forodesine
11%
Acute Lymphoblastic Leukemia
11%
Vidarabine
10%
Mantle Cell Lymphoma
10%
Guanine Arabinoside
10%
Phosphotransferase
10%
Caspase
9%
Bendamustine
9%
Myeloma
8%
Neoplasm
8%
Prodrug
7%
Chemotherapy
7%
Ribonucleotide Reductase
7%
Chronic Myeloid Leukemia
7%
Cyclophosphamide
7%
Idelalisib
7%
Myelodysplastic Syndrome
7%
Deoxycytidine Kinase
6%
Solid Malignant Neoplasm
6%
Scatter Factor Receptor
6%
Drug Resistance
6%
Keyphrases
Chronic Lymphocytic Leukemia
59%
Fludarabine
36%
Triphosphate
30%
Chronic Lymphocytic Leukemia Cells
27%
Acute Myeloid Leukemia
24%
Clofarabine
23%
Hematological Malignancies
18%
Myeloma Cells
17%
8-chloro-adenosine
16%
Relapsed or Refractory
16%
Metabolism
16%
Gemcitabine
15%
Ibrutinib
13%
Nucleoside Analogues
13%
Nelarabine
13%
Ara-C
13%
Pharmacokinetics
11%
Relapsed or Refractory Acute Myeloid Leukemia
11%
Myeloid Cell leukemia-1 (Mcl-1)
11%
Apoptosis
11%
Phase II Study
11%
Mantle Cell Lymphoma
10%
Cell Death
10%
Cytarabine
10%
Venetoclax
10%
Leukemia
9%
Mechanism of Action
9%
DNA Synthesis
9%
Complete Remission
9%
Bendamustine
9%
RNA Synthesis
8%
Cytotoxicity
8%
Ara-CTP
8%
Induced Apoptosis
8%
Pim Kinase Inhibitor
7%
Multiple Myeloma
7%
SGI-1776
7%
Human Leukemia Cells
7%
Adenosine
7%
Amino
7%
Phosphorylation
7%
Phase I Study
6%
Combination Therapy
6%
Anti-apoptotic Proteins
6%
Pediatric Patients
6%
Monophosphate
6%
5-bisphosphate
6%
Chronic Myeloid Leukemia
6%
T Cells
6%
Arabinofuranosylcytosine
6%
Biochemistry, Genetics and Molecular Biology
Programmed Cell Death
26%
Cytarabine
18%
B Cell
18%
Myeloid
17%
Gemcitabine
16%
Adenosine
16%
Phosphotransferase
16%
Kinase
16%
Adenosine Triphosphate
14%
Nucleoside Analog
12%
Metabolic Pathway
11%
Cytotoxicity
11%
Cell Death
11%
Transcription
11%
Fludarabine
11%
DNA Synthesis
10%
Stromal Cell
10%
Cancer Cell
9%
T Cell
8%
Pharmacokinetic
8%
RNA
7%
Pharmacodynamics
7%
Lymphocyte
7%
Messenger RNA
6%
Clinical Trial
6%
Oxidative Phosphorylation
6%
Protein Kinase B
6%
Anticancer
5%
Caspase
5%
Cell Survival
5%
Cytidine Triphosphate
5%
Nucleoside
5%
Mitophagy
5%
Deoxyguanosine
5%
DNA Repair
5%
Wild Type
5%